{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:59:10Z","timestamp":1789001950654,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1053\/j.semtcvs.2020.11.011","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T13:06:36Z","timestamp":1604927196000},"page":"907-918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"33","author":[{"given":"Nuno","family":"Vouga Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gouveia Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno C.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds M.","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-5673","authenticated-orcid":false,"given":"Daniel","family":"Caldeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2020.11.011_bib0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s41669-016-0007-y","article-title":"Utilization, spending, and price trends for quinolones in the US medicaid programs: 25 years\u2019 experience 1991-2015","volume":"1","author":"Almalki","year":"2017","journal-title":"PharmacoEco Open"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0002","series-title":"Outpatient Antibiotic Prescriptions \u2014 United States","year":"2015"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0003","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995 to 2002","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0004","series-title":"FDA Warns About Increased Risk of Ruptures or Tears in the Aorta Blood Vessel With Fluoroquinolone Antibiotics in Certain Patients","year":"2018"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0005","series-title":"FDA Requires Label Changes to Warn of Risk for Possibly Permanent Nerve Damage From Antibacterial Fluoroquinolone Drugs Taken by Mouth or by Injection","year":"2013"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0006","unstructured":"European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. Available at: https:\/\/www.ema.europa.eu\/en\/news\/disabling-potentially-permanent-side-effects-lead-suspension-restrictions-quinolone-fluoroquinolone. Published 2018. Accessed November 20, 2020"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0007","unstructured":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Available at: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm628753.htm. Published 2019. Accessed March 7, 2019"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0008","doi-asserted-by":"crossref","first-page":"22287","DOI":"10.1074\/jbc.M115.671222","article-title":"Nonantibiotic effects of fluoroquinolones in mammalian cells","volume":"290","author":"Badal","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0009","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.112.097097","article-title":"Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection","volume":"126","author":"Kurihara","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0010","first-page":"11","article-title":"Abdominal aortic aneurysm: A comprehensive review","volume":"16","author":"Aggarwal","year":"2011","journal-title":"Exp Clin Cardiol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0011","doi-asserted-by":"crossref","first-page":"w14489","DOI":"10.4414\/smw.2017.14489","article-title":"Acute aortic dissection: Pathogenesis, risk factors and diagnosis","volume":"147","author":"Gawinecka","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0013","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0014","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","article-title":"Oral fluoroquinolone and the risk of aortic dissection","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0015","doi-asserted-by":"crossref","first-page":"k678","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: Nationwide cohort study","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0016","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0017","series-title":"Introduction to Meta-Analysis","first-page":"107","article-title":"Introduction to meta-analysis","author":"Michael Borenstein","year":"2009"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0018","article-title":"Influenza vaccination in patients with heart failure: A systematic review and meta-analysis of observational studies","author":"Rodrigues","year":"2019","journal-title":"Heart"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0019","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Stat Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0020","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2013-303950","article-title":"Caffeine does not increase the risk of atrial fibrillation: A systematic review and meta-analysis of observational studies","volume":"99","author":"Caldeira","year":"2013","journal-title":"Heart"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0022","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0023","doi-asserted-by":"crossref","first-page":"e4260","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: Systematic review and meta-analysis","volume":"345","author":"Caldeira","year":"2012","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0024","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analyses\u2014Sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0026","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0027","series-title":"GDT: GRADEpro Guideline Development Tool [Software]","year":"2019"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0028","first-page":"375","article-title":"Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2019","journal-title":"Cochrane Handb Syst Rev Interv"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0029","unstructured":"Page MJ, Higgins JPT, Sterne JAC. Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from HYPERLINK http:\/\/www.training.cochrane.org\/handbookwww.training.cochrane.org\/handbook\/current\/chapter-13#section-13-3-5-4. Acessed November 20, 2020"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: A longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0031","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0032","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2018.12.012","article-title":"Short-term risk of aortoiliac aneurysm or dissection associated with fluoroquinolone use","volume":"73","author":"Maumus-Robert","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0033","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11606-018-4774-2","article-title":"What fluoroquinolones have the highest risk of aortic aneurysm? A case\/non-case study in VigiBase(R)","volume":"34","author":"Sommet","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0034","doi-asserted-by":"crossref","first-page":"e13331","DOI":"10.1111\/ijcp.13331","article-title":"Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system","volume":"73","author":"Meng","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0035","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0036","first-page":"1853","article-title":"Infected (mycotic) aneurysms: Spectrum of imaging appearances and management","volume":"28","author":"Lee","year":"2008","journal-title":"Radiogr Rev Publ Radiol Soc North Am Inc"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0037","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1067\/mva.2001.118084","article-title":"Infected aortic aneurysms: Aggressive presentation, complicated early outcome, but durable results","volume":"34","author":"Oderich","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0038","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: A systematic review","volume":"36","author":"Stephenson","year":"2013","journal-title":"Drug Saf"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0039","article-title":"Fluoroquinolones and the risk of aortopathy: A systematic review and meta-analysis","author":"Noman","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.amjmed.2017.06.029","article-title":"Aortic dissection and aortic aneurysms associated with fluoroquinolones: A systematic review and meta-analysis","volume":"130","author":"Singh","year":"2017","journal-title":"Am J Med"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0041","doi-asserted-by":"crossref","DOI":"10.2174\/1871525717666190402121958","article-title":"Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: A systematic review and meta-analysis","author":"Rawla","year":"2019","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0042","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40264-019-00828-z","article-title":"Fluoroquinolone use and the risk of collagen-associated adverse events: A systematic review and meta-analysis","volume":"42","author":"Yu","year":"2019","journal-title":"Drug Saf"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0043","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-020-01354-y","article-title":"Relationship between fluoroquinolones and the risk of aortic diseases: A meta-analysis of observational studies","volume":"20","author":"Dai","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0044","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.CIR.0000154569.08857.7A","article-title":"Thoracic and abdominal aortic aneurysms","volume":"111","author":"Isselbacher","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2020.11.011_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamaophthalmol.2015.6205","article-title":"Association between oral fluoroquinolone use and retinal detachment","volume":"134","author":"Raguideau","year":"2016","journal-title":"JAMA Ophthalmol"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067920304044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067920304044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:32:21Z","timestamp":1760905941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067920304044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"alternative-id":["S1043067920304044"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2020.11.011","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2020.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}